Home | About Us | Grants | Resources | News & Events | Community

Vision: We may not be there yet, but we are closer than we were yesterday.


About Us
arrowHistory & Background

arrowGrant Opportunities
arrowGrant Process
arrowASN Co-Grants
arrow2015 Grant Recipient
2013 Grant Recipient
arrowTranslational Research

arrowPatient Registries
arrowMedical Experts
arrowBio Banks

News & Events
arrow2018 MN Conference in Bergamo
HFE Gene Linked to MN
arrowCureGN Study at Columbia
Protein Linked to Kidney Failure
arrowNIH Renews NEPTUNE Funding
Childhood Stress not trigger for MS
arrowLevin succeeds Remuzzi at ISN

arrowSalant receives Hamburger Award
arrowDrug for MS & Alzheimer's
arrowNeurons & Salt
arrowAutoimmune-Allergy Connection
arrowA Cause of Recurrent MN
arrowBlood Test Detects Kidney Rejection
Genotyping of Risk Alleles
arrowLink to Gene Variants

arrowBlood Test to Detect MN
arrowMN, an Autoimmune Disease
arrowKey Molecule Impacts Mice
arrowLa Jolla Institute
arrowGluten Specific T-cells
arrowHuman Gene Pool
arrowVitamin D & Clinical Outcomes
arrowBovine Serum Albumen
Variations in HLA-DQA1 & PLA2R1
arrowKlotho and Kidney Disease
arrowLink between MN and Milk (NEJM)

arrowASN News Release
arrowMario Negri Recap
arrowHyper-IgG4 Syndrome News Release
arrowAdvances in Kidney Disease (RSS)
arrowKidney Disease News (RSS)
arrowNew Patents (RSS)
arrowScience Daily (RSS)
arrowUpcoming Events
arrowEvents Archive

arrowPublic Service Announcement


Photo Recap (Set 3):
International Conference on
Membranous Nephropathy

Rollover images and click to see larger photos:


Set 3

The International Conference on Membranous Nephropathy
Bergamo, Italy
May 6-7, 2011

Under the supervision of Giuseppe Remuzzi, M.D. F.R.C.P., the International Conference on Membranous Nephropathy (MN) covered the latest research and the translational opportunities to create therapies to address the syndrome. Dr. Remuzzi is the Director of the Mario Negri Institute for Pharmacological Research of the Negri Bergamo Laboratories, and Director of the Department of Nephrology and Dialysis at the Ospedali Riuniti of Bergamo Hospital in Bergamo, Italy.

Learn more about Mario Negri Institute and MN in the News Release here.

Prior to his current role, Dr. Remuzzi was appointed to Professor of Nephrology and Director of the Division of Immunology and Organ Transplantation at Bergamo Hospital. His serves on several scientific advisory boards, including Tissera, Inc., a tissue transplantation biotechnology firm in Israel.

Dr. Remuzzi has authored more than 700 scientific articles, reviews and monographs and serves on editorial boards of numerous journals including the prestigious New England Journal of Medicine. He is a member of the International Advisory Board of The Lancet. In recognition of his achievements, he has been awarded in 1998 honorary memberships in the Association of American Physicians and the British Royal College of Physicians. In 2001 he was nominated Chairman of the Research Committee of the COMGAN (Commission on Global Advancement of Nephrology) of the International Society of Nephrology.

The conference was an invitation-only event, however, The Halpin Foundation will publish the latest news from the Conference on this web site.